Richard Ginn - 26 Apr 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role
Chief Technology Officer, Director
Signature
/s/ Richard Ginn
Issuer symbol
TNON
Transactions as of
26 Apr 2022
Net transactions value
$0
Form type
3
Filing time
26 Apr 2022, 21:34:29 UTC
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNON Common Stock 572,168 26 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Stock Options 26 Apr 2022 Common Stock 56,500 $5.20 Direct F2, F3
holding TNON Stock Options 26 Apr 2022 Common Stock 5,499 $7.06 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,738 shares of common stock issuable upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022.
F2 Richard Ginn was granted an option to purchase 113,000 shares (or 56,500 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $2.60 (or $5.20 post-split) per share with a grant date of May 1, 2021, subject to monthly equal vesting over a three-year period commencing April 1, 2021.
F3 18,833 shares of common stock underlying stock options granted on May 1, 2021 have vested and are exercisable as of April 26, 2022.
F4 Richard Ginn was granted an option to purchase 10,998 shares (or 5,499 shares post-split) of common stock at an exercise price of $3.53 (or $7.06 post-split), per share with a grant date of July 19, 2021, subject to monthly equal vesting over a three-year period commencing July 19, 2021.
F5 1,374 shares of common stock underlying stock options granted on July 19, 2021 have vested and are exercisable as of April 26, 2022.